7th Annual Macrocyclics & Constrained Peptides
April 10-11, 2019
San Diego, CA
Cell-Penetrating, Bigger Molecules for Oral-Based Therapeutics
- Co-Founder Scott Lokey will give a presentation entitled “The Permeability Landscape around Lariat Cyclic Peptides” during the “Designing Challenges for Macrocyclic Peptides” session.
- Chief Scientific Officer David Spellmeyer will give a presentation entitled “Macrocycles Targeting Intracellular PPIs for Addressing Refractory Oncology Targets” during the “Target Modulation with Macrocycles” session.
6th Annual Peptides Congress
April 24-25, 2019
CEO & President David J. Earp will be presenting
24th Annual International Partnering Conference
November 5-7, 2018
Bella Center Copenhagen, Copenhagen, Denmark
President and CEO David J. Earp will be attending.
BIO Investor Forum
October 17-18, 2018
Westin St. Francis Hotel, San Francisco, CA
President and CEO David J. Earp will be presenting during the Company Presentations session.
13th Annual Drug Discovery Chemistry meeting for Macrocycles & Constrained Peptides
April 4-5, 2018
Hilton Bayfront in San Diego, California
Co-Founder Scott Lokey will be presenting during the “Cyclic Peptides: Drug Development Challenges” session.
3rd Annual Oligonucleotide & Peptide Therapeutics meeting for Peptide Discovery and Delivery
March 26-28, 2018
Boston Marriott in Cambridge, MA
CSO David Spellmeyer will be presenting during the “Macrocyclic and Constrained Peptides” session.
Discovery on Target
September 25-29, 2017
The Westin Copley Place, Boston , MA
President and CEO David J. Earp will be presenting during the “Case Studies Macrocyclic Peptides for Specific Targets” session.